[1]Locationinpatent:schemeortableSaku,Osamu;Saki,Mayumi;Kurokawa,Masako;Ikeda,Ken;Takizawa,Takuya;Uesaka,Noriaki[BioorganicandMedicinalChemistryLetters,2010,vol.20,#3,p.1090-1093]
386715-34-0
143209-01-2
185617-14-5 | D-Homotyrosine hydrobromide | AA00APMG | MFCD01075128
19635-96-2 | H-Leu-nhnh-z tfa | AA00APWM | MFCD00058483
146764-24-1 | (2R)-2-Acetamido-3-((5-hydroxy-2-pentyltetrahydrofuran-3-yl)thio)propanoic acid | AA00AQ7B | MFCD03412011
167303-65-3 | N-Methoxy-n-methylcyclopentanecarboxamide | AA00AQBA | MFCD12546236
1437794-63-2 | 1,3-Bis(2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea | AA00AQG5 | MFCD24448804
194490-25-0 | 5-(Benzyloxy)-1h-indole-3-carbonitrile | AA00AQMX | MFCD13193421
1800098-36-5 | Quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate | AA00AR4L | MFCD29036741
169751-72-8 | Ho-peg4-ch2co2t-bu | AA00ARUB | MFCD27635170
1982270-12-1 | (1R)CYCLOPROPYL(2-FLUOROPHENYL)METHYLAMINE HYDROCHLORIDE | AA00AS8F | MFCD22371842
185619-66-3 | tert-Butyl 3-ethynylphenylcarbamate | AA00ASRI | MFCD14585306